ArticleFrontiers in pharmacology2018

Biodegradable Nanoparticles Mediated Co-delivery of Erlotinib (ELTN) and Fedratinib (FDTN) Toward the Treatment of ELTN-Resistant Non-small Cell Lung Cancer (NSCLC) via Suppression of the JAK2/STAT3 Signaling Pathway.

Donglai Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.